Literature DB >> 25229869

Bactericidal activity of nukacin ISK-1: an alternative mode of action.

Urmi Roy1, Mohammad Riazul Islam, Jun-ichi Nagao, Hiroshi Iida, Abdullah-Al Mahin, Mengqi Li, Takeshi Zendo, Jiro Nakayama, Kenji Sonomoto.   

Abstract

We previously reported bacteriostatic action of nukacin ISK-1 against Bacillus subtilis JCM 1465(T). Here, we found its bactericidal activity against Micrococcus luteus DSM 1790 and Staphylococcus simulans 22, showing decrease in cell viability, cell lysis, and dissipation of the membrane potential. Moreover, leakage of small molecules such as K(+), suggested the formation of small-sized or specific K(+)-conducting-pores by nukacin ISK-1.

Entities:  

Keywords:  antimicrobial peptide; bactericidal activity; lantibiotic; mode of action; unusual amino acid

Mesh:

Substances:

Year:  2014        PMID: 25229869     DOI: 10.1080/09168451.2014.918485

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  4 in total

Review 1.  Efficiency of Antimicrobial Peptides Against Multidrug-Resistant Staphylococcal Pathogens.

Authors:  Mi Nguyen-Tra Le; Miki Kawada-Matsuo; Hitoshi Komatsuzawa
Journal:  Front Microbiol       Date:  2022-06-09       Impact factor: 6.064

2.  High Frequency and Diversity of Antimicrobial Activities Produced by Nasal Staphylococcus Strains against Bacterial Competitors.

Authors:  Daniela Janek; Alexander Zipperer; Andreas Kulik; Bernhard Krismer; Andreas Peschel
Journal:  PLoS Pathog       Date:  2016-08-04       Impact factor: 6.823

3.  The lantibiotic nukacin ISK-1 exists in an equilibrium between active and inactive lipid-II binding states.

Authors:  Daisuke Fujinami; Abdullah-Al -Mahin; Khaled M Elsayed; Mohammad R Islam; Jun-Ichi Nagao; Urmi Roy; Sabrina Momin; Takeshi Zendo; Daisuke Kohda; Kenji Sonomoto
Journal:  Commun Biol       Date:  2018-09-25

4.  New insights into the mode of action of the lantibiotic salivaricin B.

Authors:  Abdelahhad Barbour; John Tagg; Osama K Abou-Zied; Koshy Philip
Journal:  Sci Rep       Date:  2016-08-16       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.